HOME > 教室について > 業績リスト > 【発表論文】英文 > 2017年

2017年

  1. Kimura T. Endeavours to define optimal antithrombotic therapy after percutaneous coronary intervention. EuroIntervention. 2017 Dec 8;13(12):e1386-e1391.
  2. Kimura T. MiStent: just another example of non-inferiority? Lancet. 2017 Dec 1. pii: S0140-6736(17)33079-9.
  3. Nakagawa Y, Nishikimi T, Kuwahara K, Fujishima A, Oka S, Tsutamoto T, Kinoshita H, Nakao K, Cho K, Inazumi H, Okamoto H, Nishida M, Kato T, Fukushima H, Yamashita JK, Wijnen WJ, Creemers EE, Kangawa K, Minamino N, Nakao K, Kimura T. MiR30-GALNT1/2 Axis-Mediated Glycosylation Contributes to the Increased Secretion of Inactive Human Prohormone for Brain Natriuretic Peptide (proBNP) From Failing Hearts. J Am Heart Assoc. 2017 Feb 10;6(2). pii: e003601.
  4. Nakagawa Y, Nishikimi T, Sakai H, Ohno S, Kinoshita H, Inazumi H, Moriuchi K, Kuwahara K, Horie M, Kimura T. Macro-pro-B-type natriuretic peptide (proBNP) and hidden macro-Nterminal proBNP: Case report. Clin Biochem. 2017 Nov 2. pii: S0009-9120(17)30623-9.
  5. Imai M, Yoshida M, Toyota T, Shiomi H, Shizuta S, Saito N, Kimura T. Successful catheter treatment using pre-operative 3D organ model simulation for atrial septal defect with dextrocardia and interrupted inferior vena cava to the superior vena cava. JACC: Cardiovascular Interventions in press.
  6. Shiomi H, Kosuge M, Morimoto T, Watanabe Hiroki, Taniguchi T, Nakatsuma K, Toyota T, Yamamoto E, Shizuta S, Tada T, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Kimura K, Kimura T; CREDO-Kyoto AMI Investigators. QRS Score at Presentation Electrocardiogram Is Correlated With Infarct Size and Mortality in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention. Circ J. 2017 Jul 25;81(8):1129-1136.
  7. Shiomi H, Morimoto T, Kitaguchi S, Nakagawa Y, Ishii K, Haruna Y, Takamisawa I, Motooka M, Nakao K, Matsuda S, Mimoto S, Aoyama Y, Takeda T, Murata K, Akao M, Inada T, Eizawa H, Hyakuna E, Awano K, Shirotani M, Furukawa Y, Kadota K, Miyauchi K, Tanaka M, Noguchi Y, Nakamura S, Yasuda S, Miyazaki S, Daida H, Kimura K, Ikari Y, Hirayama H, Sumiyoshi T, Kimura T; ReACT Investigators. The ReACT Trial: Randomized Evaluation of Routine Follow-up Coronary Angiography After Percutaneous Coronary Intervention Trial. JACC Cardiovasc Interv. 2017 Jan 23;10(2):109-117.
  8. Watanabe Hirotoshi, Morimoto T, Shiomi H, Yamaji K, Shizuta S, Furukawa Y, Nakagawa Y, Kadota K, Ando K, Sakata R, Hanyu M, Nishiwaki N, Komiya T, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-2 investigators. Documented coronary atherothrombosis as the cause of death in post-discharge patients after coronary revascularization. Cardiovasc Revasc Med. 2017 Dec 21. pii: S1553-8389(17)30461-X.
  9. Tazaki J, Inoue K, Higami H, Higashitani N, Toma M, Saito N, Kawatou M, Kimura T. Thoracic endovascular aortic repair with branched Inoue Stent Graft for arch aortic aneurysms. J Vasc Surg. 2017 Nov;66(5):1340-1348.e5.
  10. Yoshida Y, Yamanaka S. Induced Pluripotent Stem Cells 10 Years Later: For Cardiac Applications. Circ Res. 2017 Jun 9;120(12):1958-1968.
  11. Nakao T, Horie T, Baba O, Nishiga M, Nishino T, Izuhara M, Kuwabara Y, Nishi H, Usami S, Nakazeki F, Ide Y, Koyama S, Kimura M, Sowa N, Ohno S, Aoki H, Hasegawa K, Sakamoto K, Minatoya K, Kimura T, Ono K. Genetic Ablation of MicroRNA-33 Attenuates Inflammation and Abdominal Aortic Aneurysm Formation via Several Anti-Inflammatory Pathways. Arterioscler Thromb Vasc Biol. 2017 Nov;37(11):2161-2170.
  12. Nishiga M, Horie T, Kuwabara Y, Nagao K, Baba O, Nakao T, Nishino T, Hakuno D, Nakashima Y, Nishi H, Nakazeki F, Ide Y, Koyama S, Kimura M, Hanada R, Nakamura T, Inada T, Hasegawa K, Conway SJ, Kita T, Kimura T, Ono K.MicroRNA-33 Controls Adaptive Fibrotic Response in the Remodeling Heart by Preserving Lipid Raft Cholesterol.Circ Res. 2017 Mar 3;120(5):835-847.
  13. Taniguchi T, Higuchi T, Tazaki J, Saito N, Kimura T. Successful Percutaneous Transcatheter Angioplasty of Radial Artery in Thromboangiitis Obliterans (Buerger's Disease). JACC Cardiovasc Interv. 2017 Sep 6. pii: S1936-8798(17)31470-X.
  14. Taniguchi T, Morimoto T, Shiomi H, Ando K, Kanamori N, Murata K, Kitai T, Kawase Y, Izumi C, Miyake M, Mitsuoka H, Kato M, Hirano Y, Matsuda S, Inada T, Nagao K, Murakami T, Takeuchi Y, Yamane K, Toyofuku M, Ishii M, Minamino-Muta E, Kato T, Inoko M, Ikeda T, Komasa A, Ishii K, Hotta K, Higashitani N, Kato Y, Inuzuka Y, Maeda C, Jinnai T, Morikami Y, Saito N, Minatoya K, Kimura T; CURRENT AS Registry Investigators. High- Versus Low- Gradient Severe Aortic Stenosis: Demographics, Clinical Outcomes, and Effects of the Initial Aortic Valve Replacement Strategy on Long-Term Prognosis. Circ Cardiovasc Interv. 2017 May;10(5). pii: e004796.
  15. Taniguchi T, Shiomi H, Morimoto T, Watanabe Hirotoshi, Ono K, Shizuta S, Kato T, Saito N, Kaji S, Ando K, Kadota K, Furukawa Y, Nakagawa Y, Horie M, Kimura T. Incidence and Prognostic Impact of Heart Failure Hospitalization During Follow-Up After Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction. Am J Cardiol. 2017 Jun 1;119(11):1729-1739.
  16. Toyota T, Morimoto T, Shiomi H, Ando K, Ono K, Shizuta S, Kato T, Saito N, Furukawa Y, Nakagawa Y, Horie M, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators. Ad hoc vs. Non-ad hoc Percutaneous Coronary Intervention Strategies in Patients With Stable Coronary Artery Disease. Circ J. 2017 Mar 24;81(4):458-467.
  17. Toyota T, Morimoto T, Shiomi H, Yamaji K, Ando K, Ono K, Shizuta S, Saito N, Kato T, Kaji S, Furukawa Y, Nakagawa Y, Kadota K, Horie M, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators. Single-session versus staged procedures for elective multivessel percutaneous coronary intervention. Heart. 2017 Nov 16. pii: heartjnl-2017-312117.
  18. Toyota T, Morimoto T, Shiomi H, Yoshikawa Y, Yaku H, Yamashita Y, Kimura T. Very Late Scaffold Thrombosis of Bioresorbable Vascular Scaffold: Systematic Review and a Meta- Analysis. JACC Cardiovasc Interv. 2017 Jan 9;10(1):27-37. doi: 10.1016/j.jcin.2016.10.027.
  19. Toyota T, Shiomi H, Morimoto T, Natsuaki M, Kimura T. Short versus prolonged dual antiplatelet therapy (DAPT) duration after coronary stent implantation: A comparison between the DAPT study and 9 other trials evaluating DAPT duration. PLoS One. 2017 Sep 20;12(9):e0174502.
  20. Kawaji T, Shizuta S, Morimoto T, Aizawa T, Yamagami S, Yoshizawa T, Ota C, Onishi N, Sasaki Y, Yahata M, Nakai K, Hayano M, Nakao T, Hanazawa K, Goto K, Doi T, Ono K Kimura T. Very long-term clinical outcomes after radiofrequency catheter ablation for atrial fibrillation: A large single-center experience. Int J Cardiol. 2017 Dec 15;249:204-213.
  21. Kawaji T, Shiomi H, Morishita H, Morimoto T, Taylor CA, Kanao S, Koizumi K,Kozawa S, Morihiro K, Watanabe Hirotoshi, Tazaki J, Imai M, Saito N, Shizuta S, Ono K, Togashi K, Kimura T. Feasibility and diagnostic performance of fractional flowreserve measurement derived from coronary computed tomography angiography in real clinical practice.Int J Cardiovasc Imaging. 2017 Feb;33(2):271-281.
  22. Hayano M, Makiyama T, Kamakura T, Watanabe Hirotoshi, Sasaki K, Funakoshi S, Wuriyanghai Y, Nishiuchi S, Harita T, Yamamoto Y, Kohjitani H, Hirose S, Yokoi F, Chen J, Baba O, Horie T, Chonabayashi K, Ohno S, Toyoda F, Yoshida Y, Ono K, Horie M, Kimura T. Development of a Patient-Derived Induced Pluripotent Stem Cell Model for the Investigation of SCN5A-D1275N-Related Cardiac Sodium Channelopathy. Circ J. 2017 Nov 24;81(12):1783-1791.
  23. Yamamoto Y, Makiyama T, Harita T, Sasaki K, Wuriyanghai Y, Hayano M, Nishiuchi S, Kohjitani H, Hirose S, Chen J, Yokoi F, Ishikawa T, Ohno S, Chonabayashi K, Motomura H, Yoshida Y, Horie M, Makita N, Kimura T. Allele-specific Ablation Rescues Electrophysiological Abnormalities in a Human iPS Cell Model of Long-QT Syndrome with a CALM2 Mutation. Hum Mol Genet. 2017 May 1;26(9):1670-1677.
  24. Nishiuchi S, Makiyama T, Aiba T, Nakajima K, Hirose S, Kohjitani H, Yamamoto Y, Harita T, Hayano M, Wuriyanghai Y, Chen J, Sasaki K, Yagihara N, Ishikawa T, Onoue K, Murakoshi N, Watanabe I, Ohkubo K, Watanabe Hirotoshi, Ohno S, Doi T, Shizuta S, Minamino T, Saito Y, Oginosawa Y, Nogami A, Aonuma K, Kusano K, Makita N, Shimizu W, Horie M, Kimura T. Gene-Based Risk Stratification for Cardiac Disorders in LMNA Mutation Carriers. Circ Cardiovasc Genet. 2017 Dec;10(6). pii: e001603.
  25. Nakatsuma K, Shiomi H, Natsuaki M, Morimoto T, Igarashi K, Kadota K, Muramatsu T, Tanabe K, Morino Y, Akasaka T, Nakagawa Y, Kozuma K, Kimura T; RESET and NEXT investigators. Second-generation versus first-generation drug-eluting stents in patients with and without diabetes mellitus: pooled analysis from the RESET and NEXT trials. Cardiovasc Interv Ther. 2017 Feb 1.
  26. Nakatsuma K, Taniguchi T, Morimoto T, Shiomi H, Ando K, Kanamori N, Murata K, Kitai T, Kawase Y, Izumi C, Miyake M, Mitsuoka H, Kato M, Hirano Y, Matsuda S, Inada T, Nagao K, Murakami T, Takeuchi Y, Yamane K, Toyofuku M, Ishii M, Minamino-Muta E, Kato T, Inoko M, Ikeda T, Komasa A, Ishii K, Hotta K, Higashitani N, Kato Y, Inuzuka Y, Maeda C, Jinnai T, Morikami Y, Saito N, Minatoya K, Kimura T; CURRENT AS Registry Investigators. Prognostic Impact of Peak Aortic Jet Velocity in Conservatively Managed Patients With Severe Aortic Stenosis: An Observation From the CURRENT AS Registry. J Am Heart Assoc. 2017 Jul 24;6(7). pii: e005524.
  27. Nakatsuma K, Watanabe S, Tokushige A, Yamamoto E, Bao B, Watanabe Hiroki, Kimura T, Saito N. Coronary bifurcation model created using a novel directional heat injury catheter. Cardiovasc Revasc Med. 2017 Jun 7. pii: S1553-8389(17)30194-X.
  28. Watanabe Hiroki, Morimoto T, Shiomi H, Kawaji T, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Kimura T; CREDO-Kyoto AMI investigators. Chronic total occlusion in noninfarct- related artery is associated with increased short-and long-term mortality in patients with ST-segment elevation acute myocardial infarction complicated by cardiogenic shock (from the CREDO-Kyoto AMI registry). Catheter Cardiovasc Interv. 2017 Sep 30.
  29. Watanabe Hiroki, Morimoto T, Shiomi H, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Kimura T. Chronic total occlusion in a non-infarct-related artery is closely associated with increased five-year mortality in patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention (from the CREDO-Kyoto AMI registry). EuroIntervention. 2017 Feb 3;12(15):e1874-e1882.
  30. Watanabe Hiroki, Saito N, Nagata Y, Yamamoto E, Nakatsuma K, Bingyuan B, Watanabe S, Tazaki J, Kimura T, Inoue K. A novel guidewire-integrated embolic protection filter device with a handy-folding system: In vitro and in vivo performance assessment. Catheter Cardiovasc Interv. 2017 Sep 20.
  31. Watanabe Hiroki, Morimoto T, Shiomi H, Yamamoto E, Saito N, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Kimura T, CREDO-Kyoto AMI investigators. Clinical impact of revascularisation of chronic total occlusion in a non-infarct-related artery in patients with STsegment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention (from the CREDO-Kyoto AMI registry). AsiaIntervention. 2017;3:81-89.
  32. Watanabe Hiroki, Kimura T. Chronic total occlusion (CTO) in Japan. AsiaIntervention. 2017;3:7-9.
  33. Watanabe Hiroki, Morimoto T, Shiomi H, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Kimura T, CREDO-Kyoto PCI/CABG registry investigators. Intravascular-ultrasound-guided Versus Angiography-guided Percutaneous Coronary Intervention with Drug-eluting stents: five-year outcomes from the CREDO-Kyoto PCI/CABG registry. AsiaIntervention. 2018;4:26-33.
  34. Minamino-Muta E, Kato T, Morimoto T, Taniguchi T, Inoko M, Haruna T, Izumi T, Miyamoto S, Nakane E, Sasaki K, Funasako M, Ueyama K, Shirai S, Kitai T, Izumi C, Nagao K, Inada T, Tada E, Komasa A, Ishii K, Saito N, Sakata R, Minatoya K, Kimura T. Impact of the left ventricular mass index on the outcomes of severe aortic stenosis. Heart. 2017 Dec;103(24):1992-1999.
  35. Minamino-Muta E, Kato T, Morimoto T, Taniguchi T, Shiomi H, Nakatsuma K, Shirai S, Ando K, Kanamori N, Murata K, Kitai T, Kawase Y, Miyake M, Izumi C, Mitsuoka H, Kato M, Hirano Y, Matsuda S, Nagao K, Inada T, Murakami T, Takeuchi Y, Yamane K, Toyofuku M, Ishii M, Inoko M, Ikeda T, Komasa A, Tada E, Ishii K, Hotta K, Higashitani N, Jinnai T, Kato Y, Inuzuka Y, Maeda C, Morikami Y, Saito N, Sakata R, Minatoya K, Kimura T. Causes of Death in Patients with Severe Aortic Stenosis: An Observational study. Sci Rep. 2017 Nov 7;7(1):14723.
  36. Koyama S, Kuragaichi T, Sato Y, Kuwabara Y, Usami S, Horie T, Baba O, Hakuno D, Nakashima Y, Nishino T, Nishiga M, Nakao T, Arai H, Kimura T, Ono K.Dynamic changes of serum microRNA-122-5p through therapeutic courses indicates amelioration of acute liver injury accompanied by acute cardiac decompensation. ESC Heart Fail. 2017 May;4(2):112-121.
  37. Morita Y, Ohno M, Nishi K, Hiraoka Y, Saijo S, Matsuda S, Kita T, Kimura T, Nishi E. Genome-wide profiling of nardilysin target genes reveals its role in epigenetic regulation and cell cycle progression. Sci Rep. 2017 Nov 1;7(1):14801.
  38. Yamashita Y, Shiomi H, Morimoto T, Yaku H, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Abe M, Nagao K, Shizuta S, Ono K, Kimura T; CREDO-Kyoto AMI Registry Investigators. Cardiac and Noncardiac Causes of Long-Term Mortality in ST-Segment-Elevation Acute Myocardial Infarction Patients Who Underwent Primary Percutaneous Coronary Intervention. Circ Cardiovasc Qual Outcomes. 2017 Jan;10(1). pii: e002790.
  39. Yamashita Y, Shiomi H, Morimoto T, Yaku H, Kaji S, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Abe M, Akao M, Nagao K, Shizuta S, Ono K, Kimura T; CREDO-Kyoto AMI registry investigators. Transradial versus transfemoral approach in patients undergoing primary percutaneous coronary intervention for ST-elevation acute myocardial infarction: insight from the CREDO-Kyoto AMI registry. Heart Vessels. 2017 Dec;32(12):1448-1457.
  40. Yamashita Y, Shiomi H, Morimoto T, Yoneda T, Yamada C, Makiyama T, Kato T, Saito N, Shizuta S, Ono K, Kimura T. Asymptomatic Lower Extremity Deep Vein Thrombosis　- Clinical Characteristics, Management Strategies, and Long-Term Outcomes. Circ J. 2017 Nov 24;81(12):1936-1944.
  41. Yamashita Y, Uozumi R, Hamatani Y, Esato M, Chun YH, Tsuji H, Wada H, Hasegawa K, Ogawa H, Abe M, Morita S, Akao M.Current Status and Outcomes of Direct Oral Anticoagulant Use in Real-World Atrial Fibrillation Patients - Fushimi AF Registry.Circ J. 2017 Aug 25;81(9):1278-1285.
  42. Al-Huseini I, Ashida N, Kimura T. Deletion of IKKβ in smooth muscle cells induces vascular calcification through β-catenin-Runx2 signaling. J Am Heart Assoc. 2018 Jan 4;7(1). pii: e007405.
  43. Yoshikawa Y, Shiomi H, Watanabe Hirotoshi, Natsuaki M, Kondo H, Tamura T, Nakagawa Y, Morimoto T, Kimura T. Validating Utility of DAPT Score in a Large Pooled Cohort from Three Japanese PCI Studies. Circulation. 2018;137(6):551-562.
  44. Abe M, Morimoto T, Nakagawa Y, Furukawa Y, Ono K, Kato T, Kadota K, Ando K, Ishii M, Masunaga N, Akao M, Kimura T. Impact of Transient or Persistent Contrast-induced Nephropathy on Long-term Mortality After Elective Percutaneous Coronary Intervention. Am J Cardiol. 2017 Sep 19. pii: S0002-9149(17)31455-8.
  45. Ali ZA, Gao RF, Kimura T, Onuma Y, Kereiakes DJ, Ellis SG, Chevalier B, Vu MT, Zhang Z, Simonton CA, Serruys PW, Stone GW. Three-Year Outcomes With the Absorb Bioresorbable Scaffold: Individual-Patient-Data Meta-Analysis From the ABSORB Randomized Trials. Circulation. 2017 Oct 31. pii: CIRCULATIONAHA.117.031843.
  46. Ali ZA, Serruys PW, Kimura T, Gao R, Ellis SG, Kereiakes DJ, Onuma Y, Simonton C, Zhang Z, Stone GW. 2-year outcomes with the Absorb bioresorbable scaffold for treatment of coronary artery disease: a systematic review and meta-analysis of seven randomised trials with an individual patient data substudy. Lancet. 2017 Aug 19;390(10096):760-772.
  47. Aoki H, Nakamura Y, Ohno S, Makiyama T, Horie M. Cardiac conduction defects and Brugada syndrome: A family with overlap syndrome carrying a nonsense SCN5A mutation. J Arrhythm. 2017 Feb;33(1):35-39.
  48. Cannon CP, Bhatt DL, Oldgren J, Lip GYH, Ellis SG, Kimura T, Maeng M, Merkely B, Zeymer U, Gropper S, Nordaby M, Kleine E, Harper R, Manassie J, Januzzi JL, Ten Berg JM, Steg PG, Hohnloser SH; RE-DUAL PCI Steering Committee and Investigators. Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation. N Engl J Med. 2017 Oct 19;377(16):1513-1524.
  49. Chen PM, Ohno M, Hiwasa T, Nishi K, Saijo S, Sakamoto J, Morita Y, Matsuda S, Watanabe S, Kuwabara Y, Ono K, Imai M, Inoue K, Murai T, Inada T, Tanaka M, Kita T, Kimura T, Nishi E. Nardilysin is a promising biomarker for the early diagnosis of acute coronary syndrome. Int J Cardiol. 2017 Sep 15;243:1-8.
  50. Collet C, Asano T, Miyazaki Y, Tenekecioglu E, Katagiri Y, Sotomi Y, Cavalcante R, de Winter RJ, Kimura T, Gao R, Puricel S, Cook S, Capodanno D, Onuma Y, Serruys PW. Late thrombotic events after bioresorbable scaffold implantation: a systematic review and metaanalysis of randomized clinical trials. Eur Heart J. 2017 Sep 1;38(33):2559-2566.
  51. Ellis SG, Steffenino G, Kereiakes DJ, Stone GW, van Geuns RJ, Abizaid A, Nef H, Cortese B, Testa L, Menichelli M, Tamburino C, Gori T, Kimura T, Serruys PW, Brugaletta S, Sabaté M, Gao RL. Clinical, Angiographic, and Procedural Correlates of Acute, Subacute, and Late Absorb Scaffold Thrombosis. JACC Cardiovasc Interv. 2017 Sep 25;10(18):1809-1815.
  52. Fujii T, Nishi E, Ito H, Yoshitomi H, Furu M, Okabe N, Ohno M, Nishi K, Morita Y, Morita Y, Azukizawa M, Okahata A, Tomizawa T, Kimura T, Matsuda S. Nardilysin is involved in autoimmune arthritis via the regulation of tumour necrosis factor alpha secretion. RMD Open. 2017 Jul 13;3(1):e000436.
  53. Fujii Y, Matsumoto Y, Hayashi K, Ding WG, Tomita Y, Fukumoto D, Wada Y, Ichikawa M, Sonoda K, Ozawa J, Makiyama T, Ohno S, Yamagishi M, Matsuura H, Horie M, Itoh H. Contribution of a KCNH2 variant in genotyped long QT syndrome: Romano-Ward syndrome under double mutations and acquired long QT syndrome under heterozygote. J Cardiol. 2017 Jul;70(1):74-79.
  54. Fujimura T, Kawasaki T, Kimura T. Very Late Strut Overhang on Coronary Angioscopy After Bioresorbable Vascular Scaffold Implantation in a Clinically Stable Patient. Circ J. 2017 Jun 27.
  55. Fujita T, Saito N, Minakata K, Imai M, Yamazaki K, Kimura T. Transfemoral transcatheter aortic valve implantation in the presence of a mechanical mitral valve prosthesis using a dedicated TAVI guidewire: utility of a patient-specific three-dimensional heart model. Cardiovasc Interv Ther. 2017 Jul;32(3):308-311.
  56. Fukumoto D, Ding WG, Wada Y, Fujii Y, Ichikawa M, Takayama K, Fukuyama M, Kato K, Itoh H, Makiyama T, Omatsu-Kanbe M, Matsuura H, Horie M, Ohno S. Novel intracellular transport-refractory mutations in KCNH2 identified in patients with symptomatic long QT syndrome. J Cardiol. 2017 Nov 13.
  57. Giustino G, Harari R, Baber U, Sartori S, Stone GW, Leon MB, Windecker S, Serruys PW, Kastrati A, Von Birgelen C, Kimura T, Stefanini GG, Dangas GD, Wijns W, Steg PG, Morice MC, Camenzind E, Weisz G, Smits PC, Sorrentino S, Sharma M, Farhan S, Faggioni M, Kandzari D, Galatius S, Jeger RV, Valgimigli M, Itchhaporia D, Mehta L, Kim HS, Chieffo A, Mehran R. Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration. JAMA Cardiol. 2017 Aug 1;2(8):855-862.
  58. Hagiwara K, Saito N, Yamazaki K, Kimura T. Aorto-right ventricular fistula following transcatheter aortic valve implantation using a 29 mm SAPIEN XT valve. BMJ Case Rep. 2017 Apr 7;2017. pii: bcr-2017-219247.
  59. Higami H, Toyofuku M, Morimoto T, Ohya M, Fuku Y, Yamaji K, Muranishi H, Yamaji Y, Nishida K, Furukawa D, Tada T, Ko E, Ando K, Sakamoto H, Tamura T, Kawai K, Kadota K, Kimura T; AOI LMCA Stenting Registry Investigators. Impact of previous drug-eluting stent restenosis in non-left main coronary artery lesions on long-term outcomes after left main coronary artery stenting: an observation from the AOI-LMCA registry. Cardiovasc Interv Ther. 2017 Oct 19.
  60. Hiwasa T, Tomiyoshi G, Nakamura R, Shinmen N, Kuroda H, Kunimatsu M, Mine S, Machida T, Sato E, Takemoto M, Hattori A, Kobayashi K, Kawamura H, Ishibashi R, Yokote K, Kitamura K, Ohno M, Chen PM, Nishi E, Ono K, Kimura T, Takizawa H, Kashiwado K, Kamitsukasa I, Wada T, Aotsuka A, Sunami K, Kobayashi E, Yoshida Y, Matsutani T, Iwadate Y, Mori M, Uzawa A, Muto M, Sugimoto K, Kuwabara S, Iwata Y, Kobayashi Y, Terada J, Matsumura T, Sakao S, Tatsumi K, Ito M, Shimada H, Zhang XM, Kimura R, Wang H, Iwase K, Ashino H, Taira A, Arita E, Goto K, Kudo T, Doi H. Serum SH3BP5-specific antibody level is a biomarker of atherosclerosis. Immunome Res. 2017; 13 (2).
  61. Imai S, Kajiyama S, Hashimoto Y,Yamane C, Miyawaki T, Ozasa N, Tanaka M, Fukui M. Divided consumption of late-night-dinner improves glycemic excursions in patients with type 2 diabetes: A randomized cross-over clinical trial. Diabetes Res Clin Pract. 2017 Jul;129:206-212.
  62. Ito J, Sugimoto R, Nakaoka H, Yamada S, Kimura T, Hayano T, Inoue I. Systematic identification and characterization of regulatory elements derived from human endogenous retroviruses. PLoS Genet. 2017 Jul 12;13(7):e1006883.
  63. Izuhara M, Kuwabara Y, Saito N, Yamamoto E, Hakuno D, Nakashima Y, Horie T, Baba O, Nishiga M, Nakao T, Nishino T, Nakazeki F, Ide Y, Kimura M, Kimura T, Ono K. Prevention of neointimal formation using miRNA-126-containing nanoparticle-conjugated stents in a rabbit model. PLoS One. 2017 Mar 2;12(3):e0172798.
  64. Kasai Y, Toriguchi K, Hatano E, Nishi K, Ohno M, Yoh T, Fukuyama K, Nishio T, Okuno M, Iwaisako K, Seo S, Taura K, Kurokawa M, Kunichika M, Uemoto S, Nishi E.Nardilysin promotes hepatocellular carcinoma through activation of signal transducer and activator of transcription 3.Cancer Sci. 2017 May;108(5):910-917.
  65. Katayama Y, Kubo T, Akasaka T, Ino Y, Kimura K, Okura H, Shinke T, Igarashi K, Kadota K, Kozuma K, Tanabe K, Nakagawa Y, Muramatsu T, Morino Y, Kimura T; NEXT investigators. Two-year vascular responses to drug-eluting stents with biodegradable polymer versus durable polymer: An optical coherence tomography sub-study of the NEXT. J Cardiol. 2017 Dec;70(6):530-536.
  66. Kawamura M, Miyagawa S, Fukushima S, Saito A, Miki K, Funakoshi S, Yoshida Y, Yamanaka S, Shimizu T, Okano T, Daimon T, Toda T, Sawa Y. Enhanced Therapeutic Effects of Human iPS Cell Derived-Cardiomyocyte by Combined Cell-Sheets with Omental Flap Technique in Porcine Ischemic Cardiomyopathy Model. Sci Rep. 2017 Aug 18;7(1):8824
  67. Kawase Y, Taniguchi T, Morimoto T, Kadota K, Iwasaki K, Kuwayama A, Ohya M, Shimada T, Amano H, Maruo T, Fuku Y, Izumi C, Kitai T, Saito N, Minamino-Muta E, Kato T, Inada T, Inoko M, Ishii K, Komiya T, Hanyu M, Minatoya K, Kimura T; CURRENT AS Registry Investigators. Severe Aortic Stenosis in Dialysis Patients. J Am Heart Assoc. 2017 Jul 14;6(7). pii: e004961.
  68. Kawatou M, Minakata K, Sakamoto K, Nakatsu T, Tazaki J, Higami H, Uehara K, Yamazaki K, Inoue K, Kimura T, Sakata R. Comparison of endovascular repair with branched stent graft and open repair for aortic arch aneurysm. Interact Cardiovasc Thorac Surg. 2017 Aug 1;25(2):246-253.
  69. Kimura Y, Ikuta K, Kimura T, Chiba T, Oshima H, Oshima M, Nishi E, Seno H. Nardilysin regulates inflammation, metaplasia, and tumors in murine stomach. Sci Rep. 2017 Feb 23;7:43052.
  70. Kimura Y, Kato T, Inoko M. Outcomes of Treatment Strategies for Isolated Spontaneous Superior Mesenteric Artery Dissection: A Systematic Review. Ann Vasc Surg. 2017 Jul 25. pii: S0890-5096(17)30917-2.
  71. Kimura Y, Kato T, Nagao K, Izumi T, Haruna T, Ueyama K, Inada T, Inoko M.Outcomes and Radiographic Findings of Isolated Spontaneous Superior Mesenteric Artery Dissection.Eur J Vasc Endovasc Surg. 2017 Feb;53(2):276-281.
  72. Kitai T, Taniguchi T, Morimoto T, Toyota T, Izumi C, Kaji S, Kim K, Saito N, Nagao K, Inada T, Minamino-Muta E, Kato T, Inoko M, Ishii K, Koyama T, Sakata R, Furukawa Y, Kimura T; CURRENT AS registry Investigators.Different clinical outcomes in patients with asymptomatic severe aortic stenosis according to the stage classification: Does the aortic valve area matter? Int J Cardiol. 2017 Feb 1;228:244-252.
  73. Kuang Y, Miki K, Parr CJ, Hayashi K, Takei I, Li J, Iwasaki M, Nakagawa M, Yoshida Y, Saito H. Efficient and Selective Removal of Human Pluripotent Stem Cells via Ecto-Alkaline Phosphatase- Mediated Aggregation of Synthetic Peptides. Cell Chem Biol. Jun 22;24(6):685-694.e4
  74. Kuroda T, Shiomi H, Minamino-Muta E, Yamashita Y, Iwao T, Tamura H, Ueshima K, Kimura T. Evaluation of NISHIJIN e-textile for 12-lead ECG measurement through automatic ECG analyzer. Conf Proc IEEE Eng Med Biol Soc. 2017 Jul;2017:1234-1237.
  75. Morimoto T, Mineharu Y, Ono K, Nakatochi M, Ichihara S, Kabata R, Takagi Y, Cao Y, Zhao L, Kobayashi H, Harada KH, Takenaka K, Funaki T, Yokota M, Matsubara T, Yamamoto K, Izawa H, Kimura T, Miyamoto S, Koizumi A. Significant association of RNF213 p.R4810K, a moyamoya susceptibility variant, with coronary artery disease. PLoS One. 2017 Apr 17;12(4):e0175649.
  76. Nagao K, Tamura A, Morimoto T, Shimamura K, Yukawa H, Ito H, Hayashi F, Makita T, Takemura G, Sato Y, Inada T, Kimura T, Tanaka M. Liver fibrogenesis marker, 7S domain of collagen type IV in patients with acutely decompensated heart failure: Correlates, prognostic value and time course. Int J Cardiol. 2017 Jun 1;236:483-487.
  77. Nagao K, Taniguchi T, Morimoto T, Shiomi H, Ando K, Kanamori N, Murata K, Kitai T, Kawase Y, Izumi C, Miyake M, Mitsuoka H, Kato M, Hirano Y, Matsuda S, Inada T, Murakami T, Takeuchi Y, Yamane K, Toyofuku M, Ishii M, Minamino-Muta E, Kato T, Inoko M, Ikeda T, Komasa A, Ishii K, Hotta K, Higashitani N, Kato Y, Inuzuka Y, Maeda C, Jinnai T, Morikami Y, Saito N, Minatoya K, Kimura T; CURRENT AS Registry Investigators. Acute Heart Failure in Patients With Severe Aortic Stenosis　- Insights From the CURRENT AS Registry. Circ J. 2017 Oct 27.
  78. Nakamura R, Tomiyoshi G, Shinmen N, Kuroda H, Kudo T, Doi H, Mine S, Machida T, Kamitsukasa I, Wada T, Aotsuka A, Kobayashi E, Yoshida Y, Matsutani T, Iwadate Y, Mori M, Uzawa A, Muto M, Sugimoto K, Kuwabara S, Takemoto M, Hattori A, Kobayashi K, Kawamura H, Ishibashi R, Yokote K, Iwata Y, Harada J, Kobayashi Y, Terada J, Matsumura T, Sakao S, Tatsumi K, Ohno M, Chen PM, Nishi E, Ono K, Kimura T, Kitamura K, Takizawa H, Kashiwado K, Shimada H, Ito M, Goto K, Zhang XM, Kimura R, Wang H, Taira A, Arita E, Ashino H, Iwase K, Hiwasa T. An Anti-Deoxyhypusine Synthase Antibody as a Marker of Atherosclerosis-Related Cerebral Infarction, Myocardial Infarction, Diabetes Mellitus, and Chronic Kidney Disease. SM Atheroscler J. 2017; 1(1): 1001.
  79. Nakanishi H, Miki K, Komatsu KR, Umeda M, Mochizuki M, Inagaki A, Yoshida Y, Saito H. Monitoring and visualizing microRNA dynamics during live cell differentiation using microRNA-responsive non-viral reporter vectors. Biomaterials. 2017 Jun;128:121-135.
  80. Nakao K, Kuwahara K, Nishikimi T, Nakagawa Y, Kinoshita H, Minami T, Kuwabara Y, Yamada C, Yamada Y, Tokudome T, Nagai-Okatani C, Minamino N, Nakao YM, Yasuno S, Ueshima K, Sone M, Kimura T, Kangawa K, Nakao K. Endothelium-Derived C-Type Natriuretic Peptide Contributes to Blood Pressure Regulation by Maintaining Endothelial Integrity. Hypertension. 2017 Feb;69(2):286-296.
  81. Nishida K, Nakatsuma K, Shiomi H, Natsuaki M, Kawai K, Morimoto T, Kozuma K, Igarashi K, Kadota K, Tanabe K, Morino Y, Hibi K, Akasaka T, Abe M, Suwa S, Muramatsu T, Kobayashi M, Dai K, Nakao K, Tarutani Y, Fujii K, Kimura T; RESET and NEXT Investigators. Second- Generation vs. First-Generation Drug-Eluting Stents in Patients With Calcified Coronary Lesions - Pooled Analysis From the RESET and NEXT Trials. Circ J. 2017 Oct 5.
  82. Nishikawa M, Isshiki T, Kimura T, Ogawa H, Yokoi H, Miyazaki S, Ikeda Y, Nakamura M, Tanaka Y, Saito S. Risk of bleeding and repeated bleeding events in prasugrel-treated patients: a review of data from the Japanese PRASFIT studies. Cardiovasc Interv Ther. 2017 Apr;32(2):93-105.
  83. Nishikimi T, Nakagawa Y.Adrenomedullin as a Biomarker of Heart Failure.Heart Fail Clin. 2018 Jan;14(1):49-55.
  84. Ohtera S, Kanazawa N, Ozasa N, Ueshima N, Nakayama T. Proposal of quality indicators for cardiac rehabilitation after acute coronary syndrome in Japan: a modified Delphi method and practice test. BMJ Open. 2017 Jan 27;7(1):e013036.
  85. Oka T, Inoue K, Tanaka K, Toyoshima Y, Isshiki T, Kimura T, Nobuyoshi M, Shizuta S, Arita T, Fujii S, Iwakura K, Fujii K, Ando K. Duration of reverse remodeling response to cardiac resynchronization therapy: Rates, predictors, and clinical outcomes. Int J Cardiol. 2017 Sep 15;243:340-346.
  86. Okuno T, Yahagi K, Horiuchi Y, Aoki J, Simonton CA, Rapoza R, Saito S, Kimura T, Tanabe K. Very Late Restenosis Following Bioresorbable Scaffold Implantation. JACC Cardiovasc Interv. 2017 Sep 25;10(18):e167-e169.
  87. Sakane Y, Kanamoto N, Yamauchi I, Tagami T, Morita Y, Miura M, Sone M, Yasoda A, Kimura T, Nakao K, Inagaki N. Regulation of type 1 iodothyronine deiodinase by LXRα. PLoS One. 2017 Jun 15;12(6):e0179213.
  88. Seko Y, Sasaki K, Kato T, Inoko M. 123I-BMIPP single-photon emission computed tomography for diagnosing chest pain in patients with nonobstructive coronary angiograms: Takotsubo or vasospasm? Clin Case Rep. 2017 Aug 15;5(10):1716-1717.
  89. Shiode N, Kozuma K, Aoki J, Awata M, Nanasato M, Tanabe K, Yamaguchi J, Kusano H, Nie H, Kimura T; XIEVCE V/Promus PMS Investigators. The impact of coronary calcification on angiographic and 3-year clinical outcomes of everolimus-eluting stents: results of a XIENCE V/PROMUS post-marketing surveillance study. Cardiovasc Interv Ther. 2017 Jul 19.
  90. Shirai S, Taniguchi T, Morimoto T, Ando K, Korai K, Minakata K, Hanyu M, Yamazaki F, Koyama T, Komiya T, Kanamori N, Murata K, Kitai T, Kawase Y, Izumi C, Inada T, Minamino-Muta E, Kato T, Inoko M, Ishii K, Saito N, Yamanaka K, Nishiwaki N, Nakajima H, Saga T, Nakayama S, Sakaguchi G, Iwakura A, Shiraga K, Ueyama K, Fujiwara K, Miwa S, Nishizawa J, Kitano M, Kitayama H, Sakata R, Kimura T; CURRENT AS Registry Investigators. Five-Year Clinical Outcome of Asymptomatic vs. Symptomatic Severe Aortic Stenosis After Aortic Valve Replacement. Circ J. 2017 Mar 24;81(4):485-494.
  91. Shreenivas S, Kereiakes DJ, Ellis SG, Gao R, Kimura T, Onuma Y, Piard-Ruster K, Zhang Y, Koo K, Vu MT, Serruys PW8, Stone GW9. Efficacy and Safety of the Absorb Bioresorbable Vascular Scaffold in Females and Males: Results of an Individual Patient-Level Pooled Meta-Analysis of Randomized Controlled Trials. JACC Cardiovasc Interv. 2017 Sep 25;10(18):1881-1890.
  92. Sonoda K, Ohno S, Otuki S, Kato K, Yagihara N, Watanabe Hirotoshi, Makiyama T, Minamino T, Horie M. Quantitative analysis of PKP2 and neighbouring genes in a patient with arrhythmogenic right ventricular cardiomyopathy caused by heterozygous PKP2 deletion. Europace. 2017 Apr 1;19(4):644-650.
  93. Sotomi Y, Onuma Y, Dijkstra J, Miyazaki Y, Kozuma K, Tanabe K, Popma JJ, de Winter RJ, Serruys PW, Kimura T. Fate of post-procedural malapposition of everolimus-eluting polymeric bioresorbable scaffold and everolimus-eluting cobalt chromium metallic stent in human coronary arteries: sequential assessment with optical coherence tomography in ABSORB Japan trial. Eur Heart J Cardiovasc Imaging. 2017 Jan 30.
  94. Stone GW, Abizaid A, Onuma Y, Seth A, Gao R, Ormiston J, Kimura T, Chevalier B, Ben-Yehuda O, Dressler O, McAndrew T, Ellis SG, Kereiakes DJ, Serruys PW. Effect of Technique on Outcomes Following Bioresorbable Vascular Scaffold Implantation: Analysis From the ABSORB Trials. J Am Coll Cardiol. 2017 Oct 20. pii: S0735-1097(17)41047-3.
  95. Suzuki K, Mizutani Y, Soga Y, Iida O, Kawasaki D, Yamauchi Y, Hirano K, Koshida R, Kamoi D, Tazaki J, Higashitani M, Shintani Y, Yamaoka T, Okazaki S, Suematsu N, Tsuchiya T, Miyashita Y, Shinozaki N, Takahashi H, Inoue N. Efficacy and Safety of Endovascular Therapy for Aortoiliac TASC D Lesions. Angiology. 2017 Jan;68(1):67-73. Epub 2016 Mar 15.
  96. Tanabe N, Ikeda S, Tahara N, Fukuda K, Hatano M, Ito H, Nakayama T, Anzai T, Hashimoto A, Inoue T, Kajinami K, Kihara Y, Kinoshita H, Kuwahara K, Murohara T, Okazaki O, SakaiS, Satoh T, Takeda Y, Takeishi Y, Taniguchi M, Watanabe Hirotoshi, Yamamoto T, Yamauchi- Takihara K, Yoshioka K, Sasayama S.Efficacy and Safety of an Orally Administered Selective Prostacyclin Receptor Agonist, Selexipag, in Japanese Patients With Pulmonary Arterial Hypertension.Circ J. 2017 Aug 25;81(9):1360-1367.
  97. Tanada Y, Okuda J, Kato T, Minamino-Muta E, Murata I, Soga T, Shioi T, Kimura T. The metabolic profile of a rat model of chronic kidney disease. PeerJ. 2017 May 23;5:e3352.
  98. Toyofuku M, Taniguchi T, Morimoto T, Yamaji K, Furukawa Y, Takahashi K, Tamura T, Shiomi H, Ando K, Kanamori N, Murata K, Kitai T, Kawase Y, Izumi C, Miyake M, Mitsuoka H, Kato M, Hirano Y, Matsuda S, Inada T, Murakami T, Takeuchi Y, Yamane K, Ishii M, Minamino-Muta E, Kato T, Inoko M, Ikeda T, Komasa A, Ishii K, Hotta K, Higashitani N, Kato Y, Inuzuka Y, Maeda C, Jinnai T, Morikami Y, Saito N, Minatoya K, Kimura T; CURRENT AS Registry Investigators. Sex Differences in Severe Aortic Stenosis　– Clinical Presentation and Mortality. Circ J. 2017 Jul 25;81(8):1213-1221.
  99. Tsumaru S, Masumoto H, Minakata K, Izuhara M, Yamazaki K, Ikeda T, Ono K, Sakata R, Minatoya K.Therapeutic angiogenesis by local sustained release of microRNA-126 using poly lactic-co-glycolic acid nanoparticles in murine hindlimb ischemia. J Vasc Surg. 2017 Dec 11. pii: S0741-5214(17)32362-5.
  100. Uehara K, Minakata K, Saito N, Imai M, Daijo H, Nakatsu T, Sakamoto K, Yamazaki K, Kimura T, Sakata R. Use of extracorporeal membrane oxygenation in complicated transcatheter aortic valve replacement. Gen Thorac Cardiovasc Surg. 2017 Jun;65(6):329-336.
  101. Ueki J, Nakamori M, Nakamura M, Nishikawa M, Yoshida Y, Tanaka A, Morizane A, Kamon M, Araki T, Takahashi MP, Watanabe A, Inagaki N, Sakurai M. Myotonic dystrophy type 1 patientderived iPSCs for the investigation of CTG repeat instability. Sci Rep. 2017 Feb 13;7:42522.
  102. Yamagata K, Horie M, Aiba T, Ogawa S, Aizawa Y, Ohe T, Yamagishi M, Makita N, Sakurada H, Tanaka T, Shimizu A, Hagiwara N, Kishi R, Nakano Y, Takagi M, Makiyama T, Ohno S, Fukuda K, Watanabe Hirotoshi, Morita H, Hayashi K, Kusano K, Kamakura S, Yasuda S, Ogawa H, Miyamoto Y, Kapplinger JD, Ackerman MJ, Shimizu W. Genotype-Phenotype Correlation of SCN5A Mutation for the Clinical and Electrocardiographic Characteristics of Probands With Brugada Syndrome: A Japanese Multicenter Registry. Circulation. 2017 Jun 6;135(23):2255-2270.
  103. Yamaji K, Kohsaka S, Morimoto T, Fujii K, Amano T, Uemura S, Akasaka T, Kadota K, Nakamura M, Kimura T; J-PCI Registry Investigators. Relation of ST-Segment Elevation Myocardial Infarction to Daily Ambient Temperature and Air Pollutant Levels in a Japanese Nationwide Percutaneous Coronary Intervention Registry. Am J Cardiol. 2017 Mar 15;119(6):872-880.
  104. Yamamoto E, Kato T, Ozasa N, Yaku H, Inuzuka Y, Tamaki Y, Kitai T, Morimoto T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Kawashima T, Motohashi Y, Kawato M, Toyofuku M, Sato Y, Kuwahara K, Shioi T, Kimura T; KCHF study investigators. Kyoto Congestive Heart Failure (KCHF) study: rationale and design. ESC Heart Fail. 2017 Aug;4(3):216-223.
  105. Yamamoto E, Watanabe S, Bao B, Watanabe Hiroki, Nakatsuma K, Izuhara M, Ono K, Nakazawa G, Kimura T, Saito N. Preclinical evaluation of a paclitaxel-incorporated nanoparticle-coated balloon in rabbit and porcine models. Cardiovasc Revasc Med. 2017 Oct 19. pii: S1553- 8389(17)30397-4.
  106. Yoon WH, Sandoval H, Nagarkar-Jaiswal S, Jaiswal M, Yamamoto S, Haelterman NA, Putluri N, Putluri V, Sreekumar A, Tos T, Aksoy A, Donti T, Graham BH, Ohno M, Nishi E, Hunter J, Muzny DM, Carmichael J, Shen J, Arboleda VA, Nelson SF, Wangler MF, Karaca E, Lupski JR, Bellen HJ.Loss of Nardilysin, a Mitochondrial Co-chaperone for α-Ketoglutarate Dehydrogenase, Promotes mTORC1 Activation and Neurodegeneration. Neuron. 2017 Jan 4;93(1):115-131.
<< 2016年｜ 業績リストTOP ｜2018年 >>
ページの先頭へ